Quick Answer
PRP injection denials are the norm, not the exception. Unlike viscosupplementation and cortisone, PRP (platelet-rich plasma) is considered experimental or investigational by Medicare and most commercial insurers for joint injections. While the research is growing, insurance coverage remains very limited. This guide explains your options and when an appeal may or may not be worthwhile.
Important: PRP Coverage Is Very Limited
Unlike hyaluronic acid and cortisone injections, PRP is NOT covered by Medicare or most commercial insurance plans for joint injections. Most patients pay out of pocket ($500-$2,000 per injection). Before pursuing an appeal, verify whether your plan has any coverage pathway for PRP.
Why PRP Injections Get Denied
PRP therapy involves drawing your blood, concentrating the platelets, and injecting them into the affected joint. While the concept is promising and growing research supports its use, the insurance landscape is very different from other joint injections.
1. Classified as Experimental or Investigational
This is the primary denial reason. Medicare has issued a National Coverage Determination (NCD) classifying PRP as not reasonable and necessary for most orthopedic indications. Most commercial insurers follow Medicare’s lead and classify PRP as experimental or investigational. This is not a documentation issue — it is a coverage exclusion.
2. Not a Covered Benefit
Many plan documents explicitly exclude PRP from coverage. When a treatment is excluded by the plan contract, an appeal based on medical necessity is unlikely to succeed because the issue is not whether PRP is appropriate for you — it is whether the plan covers PRP at all.
3. No FDA Approval for Joint Injection Indication
While PRP preparation devices are FDA-cleared as medical devices, PRP itself does not have specific FDA approval for joint injection. Insurers use this distinction to classify it as investigational. The FDA classifies PRP systems as Class II medical devices but does not regulate the injection practice itself.
4. Insufficient Evidence Per Medical Policy
Even plans that do not have a blanket exclusion may deny PRP based on their medical policy review, which concludes that the evidence is insufficient to establish PRP as superior to standard treatments.
5. Lack of Standardization
PRP preparation varies significantly between systems and providers. The platelet concentration, leukocyte content, and activation method all differ, making it difficult for insurers to evaluate as a standardized treatment. This variability is cited by some insurers as a reason for denial.
Before You Appeal: Is It Worth It?
Unlike HA or cortisone denials, PRP denials are usually based on a plan exclusion rather than a documentation gap. If your plan explicitly excludes PRP or classifies it as experimental, an appeal based on medical necessity has a low probability of success. Read your plan’s specific language before investing time in an appeal.
When a PRP Appeal MAY Be Worthwhile
Appeals have a chance of success in these limited situations:
Your Plan Does Not Explicitly Exclude PRP
If your plan documents do not specifically exclude PRP or regenerative medicine, you may have a coverage pathway. Review your Evidence of Coverage (EOC) or Summary Plan Description (SPD) carefully.
Workers’ Compensation
Workers’ comp coverage for PRP varies by state. Some states have approved PRP for specific orthopedic injuries. If your joint condition is work-related, check your state’s workers’ compensation treatment guidelines.
Auto Injury or Personal Injury Claims
Personal injury protection (PIP) or medical payments coverage from an auto accident may cover PRP when deemed medically necessary by your treating physician, depending on state law and policy language.
Clinical Trial Participation
Some insurers cover PRP when administered as part of an IRB-approved clinical trial. This is a limited pathway but worth exploring if available in your area.
Self-Funded Employer Plan (ERISA)
Self-funded employer plans have more flexibility in coverage decisions. If your employer self-funds their health plan, they may be willing to add PRP coverage through a plan amendment. Speak with your HR or benefits department.
Step-by-Step Appeal Process (When Applicable)
Step 1: Review Your Plan Language
Before filing an appeal, obtain and carefully read:
- Your plan’s Evidence of Coverage or Summary Plan Description
- The plan’s medical policy for PRP or regenerative medicine
- The specific denial letter, including the cited exclusion or policy
If PRP is explicitly excluded by name, an appeal is unlikely to succeed and you may want to consider other options (see below).
Step 2: Gather Supporting Documentation
If you decide to appeal:
- Medical records: Documented joint condition, severity, and functional limitations
- Treatment history: Evidence that you have exhausted covered treatment options (PT, NSAIDs, cortisone, HA injections)
- Peer-reviewed research: Include 3-5 recent, high-quality studies supporting PRP for your specific condition. Meta-analyses and randomized controlled trials carry the most weight.
- Physician letter: Detailed letter explaining why PRP is medically necessary, why covered alternatives are insufficient, and citing supporting research
- PRP protocol details: Specify the PRP system to be used, platelet concentration, and administration protocol to address standardization concerns
Step 3: Write Your Appeal Letter
Your appeal must make a stronger case than for HA or cortisone because you are fighting a coverage exclusion, not just a documentation gap. See the template below.
Step 4: Submit and Follow Up
Submit via your plan’s preferred method. Be prepared for a longer timeline. Request peer-to-peer review if available.
Step 5: External Review
If internal appeal fails, external review is an option. External reviewers have overturned PRP denials in some cases, particularly when the patient has exhausted all other covered treatments and the evidence for PRP in their specific condition is strong.
Sample Appeal Letter Template
[Your Name] [Your Address] [City, State, ZIP] [Date]
[Insurance Company Name] [Appeals Department Address] [City, State, ZIP]
RE: Appeal of Denial — Platelet-Rich Plasma (PRP) Injection Member ID: [Your Member ID] Claim Number: [Claim Number from Denial Letter] Date of Service: [Date of Injection or Planned Date] Patient: [Your Name, DOB]
Dear Appeals Committee:
I am writing to appeal the denial of coverage for platelet-rich plasma (PRP) injection for my [joint condition], denied on [denial date] for the stated reason: “[exact denial reason].”
Diagnosis: [Condition] (ICD-10: [code]), confirmed by [imaging/clinical findings].
Exhausted Covered Treatment Options: I have tried and failed the following covered treatments:
- Physical therapy: [number] sessions from [start date] to [end date]. Result: [insufficient relief].
- NSAIDs: [medication] [dosage] from [start date] to [end date]. Result: [inadequate / side effects].
- Cortisone injections: [number] injections, most recent [date]. Relief lasted [X weeks] only.
- Hyaluronic acid injections: [brand, dates]. Relief was [insufficient / not sustained].
Why PRP Is Medically Necessary: Having exhausted covered treatment options, PRP represents a non-surgical alternative that may prevent or delay joint replacement surgery. Growing evidence supports PRP’s efficacy for [specific condition], including:
- [Study 1: Author, journal, year, key finding]
- [Study 2: Author, journal, year, key finding]
- [Study 3: Author, journal, year, key finding]
PRP Protocol: Treatment will use [specific PRP system], which produces a standardized preparation with [platelet concentration]. This addresses concerns about PRP variability.
Cost-Effectiveness: PRP injection ($500-$2,000) is significantly less expensive than the alternative of knee replacement surgery ($30,000-$60,000), which I am trying to avoid or delay.
I respectfully request reconsideration of this denial. Supporting documentation is enclosed.
Sincerely, [Your Signature] [Your Printed Name] [Phone Number]
Enclosures: Denial letter, medical records, imaging, treatment history, physician letter, peer-reviewed research articles, PRP system specifications
CPT and HCPCS Codes for PRP Injections
| Code Type | Code | Description |
|---|---|---|
| CPT (PRP Injection) | 0481T | Injection of autologous PRP, first site (Category III) |
| CPT (Injection) | 20610 | Arthrocentesis, aspiration and/or injection of major joint |
| CPT (Injection w/ imaging) | 20611 | Arthrocentesis with ultrasound guidance |
| CPT (Blood Draw) | 36415 | Venipuncture (blood draw for PRP preparation) |
| HCPCS (PRP) | P9020 | Platelet-rich plasma, each unit |
| ICD-10 | M17.11 | Primary OA, right knee |
| ICD-10 | M17.12 | Primary OA, left knee |
| ICD-10 | M16.11 | Primary OA, right hip |
| ICD-10 | M25.561/M25.562 | Pain in knee, right/left |
PRP Coding Is Complex
PRP uses Category III CPT codes (temporary tracking codes), which is itself a signal to insurers that the procedure is still considered emerging. Different providers may use different code combinations. Standardized coding has not been fully established for PRP injections, which contributes to claim processing difficulties.
PRP-Specific Coverage Facts
About PRP Injections
- What it is: Concentrated platelets from your own blood injected into the joint
- How it works: Growth factors in platelets are believed to promote tissue repair and reduce inflammation
- Treatment time: 30-60 minutes (blood draw, centrifuge, injection)
- Injection schedule: Typically 1-3 injections, spaced 2-4 weeks apart
- Cost without insurance: $500-$2,000 per injection
- FDA status: PRP devices are FDA-cleared (Class II), but PRP injection for joints is not specifically FDA-approved as a treatment
Medicare Coverage
Medicare does not cover PRP for joint injections. It is classified as not reasonable and necessary. This applies to both Original Medicare and Medicare Advantage plans. There is no coverage pathway through Medicare at this time.
Commercial Insurance Coverage
The vast majority of commercial plans do not cover PRP for joint injections:
- Most plans explicitly exclude PRP or regenerative medicine
- Some self-funded employer plans may offer coverage
- Workers’ compensation coverage varies by state
- A small number of plans have begun covering PRP for specific orthopedic indications
The Evidence Landscape
PRP evidence is growing but not yet at the level insurers require:
- Multiple studies show positive outcomes for knee OA
- Some meta-analyses suggest PRP may be superior to HA for knee OA
- Variability in PRP preparation protocols makes it difficult to compare studies
- Large-scale, multicenter RCTs are still needed
- The evidence trend is positive, and coverage may evolve in coming years
Alternatives If PRP Is Not Covered
If your PRP appeal is unsuccessful, consider these options:
- Hyaluronic acid injections: Covered by Medicare and most commercial plans for knee OA. Multiple FDA-approved brands available.
- Cortisone injections: Widely covered for immediate anti-inflammatory relief.
- Physical therapy: Covered by most plans and effective for joint pain management.
- Payment plans: Many providers offering PRP accept payment plans for the out-of-pocket cost.
- Health Savings Account (HSA) or Flexible Spending Account (FSA): PRP may be an eligible expense for HSA/FSA funds even when not covered by insurance.
- Clinical trials: Search ClinicalTrials.gov for PRP studies in your area. Treatment may be covered by the trial.
Tips for Managing PRP Costs
- Get a written cost estimate before treatment, including all components (blood draw, PRP preparation, injection, office visit)
- Ask about package pricing — some providers offer discounts for multiple PRP injections
- Use HSA/FSA funds if available
- Compare prices between providers. PRP pricing varies significantly.
- Ask about payment plans
- Keep receipts — even if insurance does not cover PRP now, if coverage changes in the future, you may be able to submit historical claims (check your plan’s filing deadline)
Frequently Asked Questions
How long does a PRP appeal take?
Standard appeals take about 30 days. External reviews add 30-60 days. However, because PRP denials are typically based on plan exclusions rather than documentation issues, the timeline may be shorter (quick denial of appeal) or longer (if you escalate through multiple levels).
What is the success rate for PRP appeals?
Lower than for HA or cortisone appeals. Because most denials are based on coverage exclusions rather than documentation gaps, the traditional appeal approach is less effective. External reviews occasionally overturn PRP denials, particularly when the patient has exhausted all other covered options and strong research evidence is presented.
Will PRP ever be covered by insurance?
It is possible. The evidence base for PRP is growing, and several large studies are underway. If landmark studies demonstrate clear superiority over standard treatments with standardized protocols, coverage policies may change. Some industry observers predict selective PRP coverage could emerge within the next 3-5 years for specific conditions.
Can my doctor help with the appeal?
Yes, and a strong physician letter is essential for any PRP appeal. Your doctor should cite specific peer-reviewed studies, explain why covered alternatives have failed, and describe the standardized PRP protocol that will be used. Peer-to-peer review with the plan’s medical director gives your physician the opportunity to make the case directly.
Is PRP worth paying out of pocket?
This is a personal decision. PRP has shown positive results in studies for knee osteoarthritis and some tendon injuries. Costs range from $500-$2,000 per injection. Discuss expected outcomes, number of injections needed, and alternative treatments with your physician to make an informed decision.